Orchestra BioMed Holdings (OBIO) Profit After Tax (2022 - 2025)
Historic Profit After Tax for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to -$20.8 million.
- Orchestra BioMed Holdings' Profit After Tax fell 3501.88% to -$20.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.1 million, marking a year-over-year decrease of 3018.7%. This contributed to the annual value of -$61.0 million for FY2024, which is 2423.45% down from last year.
- Latest data reveals that Orchestra BioMed Holdings reported Profit After Tax of -$20.8 million as of Q3 2025, which was down 3501.88% from -$19.4 million recorded in Q2 2025.
- In the past 5 years, Orchestra BioMed Holdings' Profit After Tax registered a high of -$5.7 million during Q1 2022, and its lowest value of -$20.8 million during Q3 2025.
- Its 4-year average for Profit After Tax is -$13.5 million, with a median of -$13.3 million in 2023.
- As far as peak fluctuations go, Orchestra BioMed Holdings' Profit After Tax plummeted by 9095.83% in 2023, and later plummeted by 1584.56% in 2024.
- Orchestra BioMed Holdings' Profit After Tax (Quarter) stood at -$9.8 million in 2022, then tumbled by 31.47% to -$12.8 million in 2023, then dropped by 26.03% to -$16.2 million in 2024, then decreased by 28.93% to -$20.8 million in 2025.
- Its Profit After Tax was -$20.8 million in Q3 2025, compared to -$19.4 million in Q2 2025 and -$18.8 million in Q1 2025.